Researchers from the University of Missouri have published a detailed review of a new AI method called flow matching, which is gaining attention for its potential to revolutionize biomedical research. The study, published in Nature Machine Intelligence, offers scientists a guide for using this technology to speed up drug discovery, improve personalized medicine, and tackle other complex biological challenges. Jianlin "Jack" Cheng, a prominent bioinformatics expert at the university, explained that flow matching enables computers to understand how biological systems change from one state to another, providing a powerful new tool for studying everything from protein folding to cancer development. Flow matching works by allowing AI models to learn how biological systems transition between different states. This approach gives researchers a more complete view of the processes that influence health and disease. Because it can model changes at multiple levels—molecular, cellular, and even tissue-wide—flow matching helps scientists explore some of biology’s most intricate questions. At the molecular level, it can predict how proteins fold, a crucial step in designing new treatments. At the cellular level, it can simulate how cells respond to various conditions, while at larger scales, it can link changes within individual cells to broader effects across tissues. The research also sets the stage for future breakthroughs. One long-term vision is the development of an AI-powered "virtual cell," a detailed digital model that could let scientists test hypotheses on computers before moving to lab experiments. This could reduce the need for animal and human studies and speed up the development of personalized medicine. Cheng believes flow matching is becoming a central framework for using generative AI in biology, with the potential to change how scientists model and understand living systems. He described it as a unifying approach that could reshape the field. The study was conducted by Alex Morehead and published in Nature Machine Intelligence in 2026. It highlights the growing role of AI in advancing biological research and offers a glimpse into how these tools might shape the future of medicine and science.